### Evidence Statement CG15AdultES189
One randomised controlled study reviewed in the ADA guideline 76 showed that thrombolytic therapy reduced mortality after acute MI in subjects with diabetes by = 42% with no increase in r isk of bleeding or stroke, and should not be withheld due to concern about retinal haemorrhage in patients with retinopathy. This study also demonstrated that the indications and co ntraindications for thrombolysis in patients with diabetes are the same as those without



[@2003]
